| Cases | Controls | P value |
---|---|---|---|
Number of participants | 1886 | 854 | Â |
Female sex, n (%) | 874 (46.4) | 511 (59.8) | <0.001 |
Age, year, median (IQR) | 65.7 (58.5–72.9) | 64.9 (60.4–69.4) | 0.72 |
Age of onset diabetes, year, median (IQR) | 55 (47–63) | N/A | N/A |
Duration of diabetes, year, median (IQR) | 8.1 (2.8–13.5) | N/A | N/A |
BMI, kg/m2, median (IQR) | 29.5 (26.4–32.7) | 25.5 (23.3–27.7) | <0.001 |
HbA1c, mmol/mol, median (IQR) | 50.8 (43.7–57.9) | 37.7 (36.1–39.3) | <0.001 |
Diabetes treatment, % (n/n-available/n-missing) | |||
 No glucose-lowering medication | 19.2 (340/1772/114) | N/A | N/A |
 Oral glucose-lowering agent | 64.3 (1140/1773/113) | N/A | N/A |
 Insulin | 32.3 (572/1772/114) | N/A | N/A |
Systolic blood pressure, mmHg, median (IQR) | 140 (129–151) | 137 (124–150) | <0.001 |
Diastolic blood pressure, mmHg, median (IQR) | 78 (71–85) | 82 (76–89) | <0.001 |
Total cholesterol, mmol/L, median (IQR) | 4.2 (3.6–4.8) | 5.6 (4.9–6.2) | <0.001 |
Triglycerides, mmol/L, median (IQR) | 1.4 (0.9–2.0) | 1.2 (0.9–1.5) | <0.001 |
HDL-cholesterol, mmol/L, median (IQR) | 1.1 (0.9–1.3) | 1.4 (1.2–1.6) | <0.001 |
LDL-cholesterol, mmol/L, median (IQR) | 2.3 (1.8–2.8) | 3.5 (2.9–4.1) | <0.001 |
Creatinine, µmol/L, median (IQR) | 78 (66–91) | 72 (63–81) | <0.001 |
eGFRÂ <Â 60Â mL/min, % (n/n-available/n-missing) | 21.2 (372/1756/130) | 5.0 (40/795/59) | <0.001 |
Cardiovascular disease, % (n/n-available/n-missing) | |||
 Any macrovascular disease | 38.0 (660/1738/148) | 8.3 (68/824/30) | <0.001 |
 Ischemic heart disease | 28.0 (497/1778/108) | 4.9 (41/842/12) | <0.001 |
 Ischemic brain disease | 12.0 (211/1757/129) | 1.4 (12/840/14) | <0.001 |
 Peripheral arterial disease | 10.8 (193/1783/103) | 2.2 (18/823/31) | <0.001 |
Microvascular diabetes complications, % (n/n-available/n-missing) | |||
 Any microvascular disease | 34.3 (561/1637/249) | N/A | N/A |
 Diabetic retinopathy | 17.3 (308/1778/108) | N/A | N/A |
 Diabetic nephropathy | 23.0 (387/1684/202) | N/A | N/A |
Family history, % (n/n-available/n-missing) | |||
 First-degree relative with T2DM | 64.4 (1104/1714/172) | 33.3 (269/809/45) | <0.001 |
 First-degree relative with CVD | 68.3 (1086/1590/296) | 68.7 (519/755/99) | 0.87 |
 Any relative with early-onset CVD | 45.0 (780/1732/154) | 41.5 (342/825 29) | 0.09 |
Descent | |||
 Caucasian descent, % (n/n-available/n-missing) | 91.9 (1613/1755) | 96.1 (810/843/11) | <0.001 |
 Age of death father, year, median (IQR) | 73 (65–82) | 75 (67–84) | <0.001 |
 Age of death mother, year, median (IQR) | 78 (70–86) | 81 (73–89) | <0.001 |